TODAY -

Transforming hope into reality for patients of drug-resistant TB

Shobha Shukla *



Multidrug-resistant TB (MDR-TB) remains a public health crisis. As per WHO's Global TB Report 2016, 480,000 people fell ill with MDR-TB in 2015, with 3 countries – India, China, and Russia – carrying the major burden and together accounting for nearly half of all MDR-TB cases globally.

Detection and treatment gaps continue to plague the MDR-TB response. In 2015, only 1 out of every 5 people needing treatment for MDR-TB were able to access it and only 52% of those who started MDR-TB treatment were cured.

"These sobering statistics remind us of our urgency to continue the fight to develop better, faster and affordable treatments that will finally bring this pandemic under control," said Dr Mel Spigelman, CEO of TB Alliance, which is working to advance several promising regimens to tackle all forms of TB.

The current MDR-TB regimen lasts for 2 years or more. It includes medicines and injectables that are not only toxic but also come at a cost that is higher than what many patients and healthcare systems can afford. Even the new 9 month MDR-TB regimen that has recently been endorsed by WHO, though shorter, does include 4 months of injectables.

However new results from 2 clinical studies conducted by TB Alliance point to an emerging paradigm, where countries may soon have the short, all-oral, and affordable drug regimens needed to treat all people with TB. Late stage clinical results from these two studies were unveiled yesterday at the 47th Union World Conference on Lung Health in Liverpool.

The NC-005 study

The NC-005 study investigates an oral, injection free regimen that purports to treat both drug-sensitive and MDR-TB with a short, simple, safe, and affordable treatment. A Phase 2b, 2 month study tested various combinations of BPaMZ—Bedaquiline (B), Pretomanid (Pa), Moxifloxacin (M) and Pyrazinamide (Z). It was conducted at 10 sites in 3 countries (Uganda, South Africa, and Tanzania).

A total of 240 patients were enrolled in the study— 180 patients with drug-sensitive TB received BPaZ and 60 patients with MDR-TB received BPaMZ. The study also investigated a simpler dosing scheme for bedaquiline, which could lead to fewer pills and an overall less complicated treatment for patients.

NC-005 showed that the best regimen was a combination of all four drugs, BPaMZ, which was examined in an arm of the trial. Data showed that at the end of 2 months, clinical study participants receiving BPaMZ cleared TB bacteria from their sputum 3 times as quickly as those on the standard treatment regimen. Almost all participants had culture conversion after the 2 months of treatment.

This is the fastest rate of culture conversion that has ever been seen and indicates the potential of BPaMZ to treat all forms of TB-drug-sensitive as well as MDR-TB with the same regimen. The regimens appeared safe. The study showed that it was possible to simplify the dosing of Bedaquiline and found that a daily dose of Bedaquiline (200 mg) is at least as active and safe as the labelled dose. This will allow for simpler daily dosing with the regimen and to be combined in a fixed dose combination.

The BPaMZ regimen is being tested to see if it can cure the vast majority of TB patients in as less as 3 months. If successful, the regimen could reshape the treatment landscape of TB, especially for people with MDR-TB, who currently face an arduous 9-24 month treatment journey that is too often unsuccessful. The results of NC-005 could pave the way to a global Phase 3 trial.

The Nix-TB Study
('Nix' means to put an end to)

It is estimated that 9% of all the MDR-TB patients suffer from extensively drug-resistant TB (XDR-TB) that is resistant to at least four commonly used anti-TB drugs. XDR-TB is often considered a death sentence. Most XDR-TB is not treated at all because of the cost and complexity of the treatment. Of those who do receive treatment, less than one third get cured.

In May 2015, TB Alliance and partners launched the world's first clinical study— the Nix-TB Study-to test a new XDR-TB drug regimen called BPaL, consisting of Bedaquiline (B), Pretomanid (Pa), and Linezolid (L) in patients who have no other treatment options. It is the first study to test an all-oral drug regimen, comprised of drugs with minimal pre-existing resistance, that has the potential to shorten, simplify, and improve treatment for XDR-TB.

Nix-TB is an open-label study that is being conducted at 2 sites in South Africa—at Sizwe Hospital in Johannesburg and at Brooklyn Chest Hospital in Cape Town. Additional sites to expand the study are planned.

Patients who have XDR-TB, or have failed their current MDR-TB treatment or who have side effects of their current MDR-TB treatment, are enrolled.Till to date, 50 patients have been enrolled in the study, including patients as young as 14 and those who are co-infected with HIV with a CD4 cell count of 50 or higher.

Initial data from the study shows the promise of BPaL to treat XDR-TB in only 6 months – Bedaquiline (400 mg daily for 2 weeks followed by 200 mg twice a week), Pretomanid (200 mg daily) and Linezolid (1200 mg daily) given orally for 6 months with the option to extend treatment to 9 months for participants who do not culture convert within 4 months. Patients are assessed at regular intervals with the aim of being cured in 6 months. After completing treatment, participants will be monitored for two years to ensure they do not relapse.

The interim results (between April 2015 and July 2016) on the first 15 participants enrolled in the study, of whom 7 were HIV positive, showed that 12 of them completed 6 months of therapy. The majority were culture negative by week 8 and no patient needed an extension of treatment. As of July 1, 2016 there have been no clinical or micro biological relapses.

As of now, 30 patients have completed 6 months of treatment and all have negative cultures of their sputum. There have been no relapses to date, although the study is still ongoing. The rest of the patients are in various stages of treatment and follow-up. 4 patients have died, but this is a substantially lower mortality than ever reported before.

The early results of this greatly simplified and shortened all oral regimen for XDR-TB appear to be encouraging in terms of both efficacy and safety. The regimen appears safe but requires medical supervision. Linezolid, which has been used off-label to treat MDR-TB, has considerable toxicity but was managed in a clinical study setting.

This is the first injection-free regimen for XDR-TB that, if successful, could transform XDR-TB treatment, with patients being cured by taking a relatively short, simple, oral and effective regimen. Importantly, the regimen would also reduce the complexity and cost of the treatment to a fraction of what it is today, facilitating the global implementation of XDR-TB treatment in resource-poor nations.

These regimens can be deployed in the context of currently available or forthcoming diagnostics. These regimens may revolutionise and markedly reshape the treatment landscape for TB by offering a common therapy for virtually all people with drug-sensitive and drug-resistant TB, and a closely related treatment for those with extensively drug-resistant TB.


* Shobha Shukla (Citizen News Service (CNS)) wrote this article for e-pao.net
Shobha Shukla is providing thematic coverage from the 47th Union World Conference on Lung Health, Liverpool, United Kingdom, with kind support from TB Alliance (Global Alliance for TB Drug Development). Follow her on Twitter @Shobha1Shukla
This article was posted on November 02, 2016.


* Comments posted by users in this discussion thread and other parts of this site are opinions of the individuals posting them (whose user ID is displayed alongside) and not the views of e-pao.net. We strongly recommend that users exercise responsibility, sensitivity and caution over language while writing your opinions which will be seen and read by other users. Please read a complete Guideline on using comments on this website.




LATEST IN E-PAO.NET
  • Shopping - 30 March #1 : Gallery
  • Status Update 30 March: Medical Directorate
  • Stop Hate in the Time of Corona
  • April Calendar for Year 2020 : Tools
  • Manipuris stranded in State : Nodal Officer
  • Covid-19 : Impact in Manipur :: News Timeline
  • Mask distributed at Kumbi
  • Nothing spreads like fear
  • Letter to Prime Minister on Racial Attack
  • Lockdown : Ensuring food for all
  • Covid-19: Manipur Strategy to Prevent & Win
  • Status Update 29 March: Medical Directorate
  • Covid-19 or Racism, which one to fight first ?
  • MHA to Chief Secys of States [Mar 29]
  • Home Delivery- Imphal Dists [Mar 29]
  • Shop List opened - Bishenpur [March 29]
  • Violating anti-defection law
  • Why PM want Leishemba to be RS MP #2
  • Manipur Govt Orders [28 March] : Gallery
  • Status Update 28 March: Medical Directorate
  • Medical material airlifted from Delhi to Imphal
  • Coronavirus Combat; not just Govt's fight
  • Lack of availability of Medicines, Water..
  • Research to plug gaps in COVID-19 testing
  • RIMS areas disinfected - [March 26] : Gallery
  • Makanmi, Namthujin, Sayoni: eMing
  • Status Update 27 March: Medical Directorate
  • Manipur Govt Orders/Directives : 27 March
  • FEGOCTA donate 1 Day Salary to CM's Fund
  • Cure for COVID
  • What a respect to the caregivers !
  • Charity Mission Committee on COVID-19
  • NH7 Weekender : Online music festival
  • Lockdown amid curfew
  • PDS rice to CMHT excluded Keishamthong?
  • Curfew in Imphal - [March 24] : Gallery
  • COVID-19 helpline numbers in Manipur
  • Screening at Mao [Mar 20] : Gallery
  • COVID 19 & Epidemic Diseases Act, 1897
  • Decoding Tax Jargon through March Ending
  • NPF urged Nagaland Govt on COVID-19
  • Food items to Child Care Institutes
  • Hand rub bottles manufactured & distributed
  • Studying the total shutdown in Manipur
  • Cheiraoba Chak Katpa #1 : Gallery
  • Social Distancing observed [Mar 25] : Gallery
  • An appeal to all on COVID19
  • What is love ? :: Poem
  • Career option in Geomagnetism
  • Kohima gets a brand new song
  • Communique on Covid-19 : Nagaland Oppn
  • CM Covid-19 Relief Fund created
  • 12 on board flight with patient quarantined
  • Quiet celebration of Cheiraoba
  • Quarantine started- Mao -Mar 24 : Gallery
  • Leikai Public curfew -Mar 24 : Gallery
  • Stop stigma of Covid 19 +Positive Friends
  • Media : Essential services during lockdown
  • Acts of Kindness, Unity among Communities
  • Racist attacks on people from North-east
  • A friend in need is a friend indeed
  • Enforce total lockdown in Nagaland :: NPCC
  • Ugly response to positive case of COVID-19
  • First Case in Manipur
  • Lamphel Nawa Kombirei at Cheiraoba
  • Woman returned from UK has Coronavirus
  • Screening at Mao - Mar 22 : Gallery
  • Why PM want Leishemba to be RS MP #1
  • Janata Curfew - 'Go corona' festival
  • Panacea for Economic Collapse: COVID-19
  • Total Lockdown till March 31st
  • Sajibu Cheiraoba - Meitei New Year Day
  • Giving racial twist to coronavirus
  • Need action to those mocking PM
  • COVID: Janata Curfew -Mar 22 #1 : Gallery
  • Manipur Govt Orders - Mar 22 : Gallery
  • Status Update 22 March: Medical Dir Lamphel
  • We will get by. We will survive.
  • Covid-19: Impact in Manipur :: Photos/News..
  • War against Corona
  • What ails Indian Railways
  • Appeal to Govt during COVID 19 crisis
  • Hats off to the men in white
  • COVID-19: Ima Keithel -March 21 : Gallery
  • Bandh on March 21 : Gallery
  • Social Justice & Democracy in Northeast
  • Sociology of Coronavirus
  • COCOMI extended help to victims of Chassad
  • The Omnipresent Fear :: Poem
  • MU Chemistry Dept makes hand sanitisers
  • COVID-19 : A blessing for Khwairamband
  • Wakching Thagi Sanarei #2 :: eRang
  • Who will rebuild Chahsat village ?
  • The untameable :: Poem
  • Importance of Fish & Fishery in Manipur
  • Challenges for female entrepreneur in India
  • The Killing Fields 2013-20 : News Timeline
  • How well prepared is Manipur?
  • More seriousness needed to fight COVID-19
  • Khongu NangGi Baasi :: Shumang Leela
  • Yaoshang Fancy Dress #1 : Gallery
  • Journalistic Challenges in Reporting Chassad
  • Paneer Our Daughter's Delight
  • Civil Site Engineer / Site Manager
  • Architectural Designer at R-Square
  • Research Officer - Financial at Amethyst
  • Chinky to Coronavirus: Racial profiling chain
  • Promises, prosperity, Rights & Responsibility
  • Wars, Devastation & events in Kakching #1
  • When Chassad Blazed Our Hearts Burnt
  • Nagas entering final phase of power struggle
  • Climate change & predator : Any link?
  • Restore Chassad village to normal condition
  • The other side of Covid-19
  • Is Manipur taking adequate steps?
  • Silencing the voice of dissent
  • Dzukou Valley, Senapati #3 : Gallery
  • Condemns the burning at Chassad Village
  • Conduct fact finding mission at Kamjong
  • Lost at the edge of uncertainty!
  • Global Youth Peace Conclave postponed
  • Entrance exams after 10 + 2
  • Workshop organized on Einstein's birthday
  • Titular King in the race for RS
  • Coronavirus, H1N1 & garbage in Imphal
  • Inner Line Permit (ILP) Demand : Timeline
  • Yaoshang Sports Meet #2 : Gallery
  • Restoring Chassad- the village with no house
  • Manipur Maharaj & House of Lords
  • COVID-19 : Hand sanitizers at Bangalore
  • Appeal to install Covid-19 test in Nagaland
  • Communal violence & over-lap ethnic aspiration
  • Understanding Ponzi scheme
  • Yaoshang Halankar #1 : Gallery
  • Yaoshang Sports Meet #1 : Gallery
  • Nano Technology in Bio Organic Fertilizer
  • Joydev Thongam: Story behind the muscles
  • COVID-19: Agent to end Economic Globalisation
  • Cannabis in HIV and AIDS
  • Is society gender-sensitive enough ?
  • Day light Thabal Chongba #1 : Gallery
  • Intl Women's Day @ Imphal : Gallery
  • International Rivers Day at Kangoi Area
  • Getting workplace ready for COVID-19
  • A Tale on Yaoshang :: Poem
  • India's improving journo-murder index
  • But Leishemba should also act politically
  • Yaoshang Marathon @ Singjamei : Gallery
  • Wangkhem Rezia : Success Stories NE
  • Guwahati Music Festival #2 : Gallery
  • A Beautiful Mind :: Poem
  • Of Purity and Arrival of Spring
  • Fr Biju Michael - Salesian South Asia
  • Yaoshang Cheng Khaiba : Gallery
  • Saroi Khangba @ Khwairamband : Gallery
  • Intl Women's Day @ Bangalore : Gallery
  • Women's health & nutirition - A glance
  • Manipur band wins at Guwahati Intl Music Fest
  • Human Beings as a bait in battle of Vice
  • 2019 Year review : Ministry of AYUSH #2
  • Journalist Sports Meet: Winner announced
  • Manipur schools to close till March 31
  • Shah's Manipur visit postponed
  • Family of late Shaiza clarifies
  • Yaoshang Rock @Sagolband :: Gallery
  • MOU - Guest House at Mandalay :: Gallery
  • #VOLUNTEER4HEALTH launched at Delhi
  • Summer breeze and Autumn leaves :: Poem
  • Why afraid of corona ?
  • Yaoshang Thabal at Bangalore postponed
  • 2nd year of PDA..lots of controversy
  • Yaoshang Mei Thaba :: Gallery
  • Until the right time, I had let you go :: Poem
  • Festival of Holi- Brahma Kumaris concept
  • Women studies as career choice
  • Consultative meeting with NPF Manipur
  • Condemns killing, calls for action against AR
  • Yaoshang Mei Loukhatpa @ Kangla :: Gallery
  • Health Camp at Pune :: Gallery
  • International Women's Day at Bangalore
  • Universal access to sexual health services
  • Health Camp on Women's Day at Pune
  • More employment for our politicians
  • Gender Resource Centre in Agriculture
  • Entry points at Indo-Myanmar border sealed
  • Peace rallies urge PM for early Naga solution
  • Reversing masculinization of India's workforce
  • Torch Rally: Journalist Sports: Gallery
  • CAA - An Act of isolation & destruction
  • Economic growth or grimmer ..Coronavirus
  • Tribal Youth Fest Marks Women's Day
  • Holi skin and hair care tips
  • Politics of South China Sea Disputes : Book
  • CM's appeal : Scale down Yaoshang revelry
  • 1st Barak Festival @Senapati: Gallery
  • Featured Front Page Photo 2020 #1: Gallery
  • Yaoshang (Holi) Festival :: Book
  • Churup Ki Mahao : Short story
  • Gender equality still a distant dream
  • Remove Chairperson, Women Commission
  • Celebrating Women's day
  • Phisakol - Film Scenes #2 :: eRang
  • yeniHTa :: Seireng
  • N Romeo promoted to Brigadier at Army
  • Cry of a Dying River
  • Never closer & this is only beginning
  • Vacancy at Info Trade, Lamphelpat
  • Ugly development at exam centre
  • Govt should think before dealing Salai case
  • Yaoshang Thabal Peisa donation: Gallery
  • Sangai Festival [Nov 28] #2 : Gallery
  • Message from a breast cancer thriver
  • Leishangthem Bala : NE Success Stories
  • A Bhakta: Treasurer- Indian Journalist Union
  • The unique 63 Saints Festival
  • Restrictions on Thabal Chongba
  • Essence of celebrating Yaoshang
  • World Meetei Convention @Cachar : Gallery
  • Women Empowerment :: Poem
  • Licypriya Kangujam to address at Washington
  • Bringing Into Disrepute ?
  • 10th Journalist Sports Meet, 2020
  • Women in Armed Forces
  • The virtues of virtual marketing
  • Negligence by child institution of Imphal East
  • From Wuhan to over 70 countries
  • Killer virus reaches neighbouring Myanmar
  • Lui-ngai-ni, Naga festival @Ukhrul #3 : Gallery
  • 13th Mega Marathon Manipur #3 : Gallery
  • A fish in the jar :: Poem
  • Naga Peace Process :: News Timeline
  • Guwahati Intl Music Festival : Gallery
  • Saroi Khangba @ Imphal #1 : Gallery
  • Eyek Tamba :: Learn Manipuri script
  • Wakching Thana Lakpada #2 :: eRang
  • Students @ Class XII Exam #2 : Gallery
  • Bangladeshki Sana Tampha #1 :: eRang
  • Manipur Legislative Assembly Building : Gallery
  • Eepan Thaba -birth ceremony : Gallery
  • Apple Farm @ Kumbi : Gallery
  • Coronavirus prevention @ Moreh : Gallery
  • Gaan-Ngai at Kakhulong #2 : Gallery
  • SPONSORED ADS